Cargando…
Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI
Cancer is associated with an increased risk of venous thromboembolism (VTE). In the CASSINI study, ambulatory cancer patients with a Khorana risk score ≥2 had a reduced risk of VTE while receiving rivaroxaban. This analysis used blood samples from CASSINI to compare biomarker levels between patients...
Autores principales: | Khorana, Alok A., Barnard, John, Wun, Ted, Vijapurkar, Ujjwala, Damaraju, CV, Moore, Kenneth Todd, Wildgoose, Peter, McCrae, Keith R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864658/ https://www.ncbi.nlm.nih.gov/pubmed/34807979 http://dx.doi.org/10.1182/bloodadvances.2021005710 |
Ejemplares similares
-
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2020) -
Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial
por: Khorana, Alok A., et al.
Publicado: (2017) -
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study
por: Vadhan‐Raj, Saroj, et al.
Publicado: (2020) -
RNA expression and risk of venous thromboembolism in lung cancer
por: Sussman, Tamara A., et al.
Publicado: (2019) -
Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated with Mortality in Patients with Prostate Cancer
por: Chaturvedi, Shruti, et al.
Publicado: (2014)